UBS Maintains a Buy on Genmab (GMAB) With a DKK2,500 PT
Genmab A/S (NASDAQ:GMAB) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential.
Posts Tagged ‘NASDAQ:GMAB’
Genmab (GMAB) Announced Results From its EPCORE NHL-2 Trial
Genmab A/S (NASDAQ:GMAB) is one of the 10 Best Growth Stocks to Buy With Huge Upside Potential. On June 15, Genmab A/S (NASDAQ:GMAB) announced results from its EPCORE NHL-2 ...
10 Best Growth Stocks to Buy With Huge Upside Potential
On July 8, Tom Lee, head of research at Fundstrat, joined CNBC to discuss how the US tariffs might impact the market, economy, and inflation.
13 Cheap Healthcare Stocks with Huge Upside Potential
On July 8, Kate Moore, Citi Wealth CIO, appeared on CNBC's 'Squawk Box' to talk about the recent rally in equities.
Leerink Raises Genmab (GMAB) Price Target, Keeps Outperform Rating
The decision came after Genmab A/S (NASDAQ:GMAB) shared new data on Rina-S in second-line and endometrial cancer treatments at the American Society of Clinical Oncology (ASCO) ...
Genmab A/S (GMAB) Reports 50% Response Rate With Rina-S in Advanced Endometrial Cancer
Results from the Phase 1/2 RAINFOL-01 trial, presented at the 2025 ASCO Annual Meeting, show that Rina-S 100 mg/m² administered every three weeks achieved a confirmed objective...
Genmab A/S (GMAB) Unveils Promising Rina-S and Epcoritamab Data at ASCO 2025
Genmab A/S (NASDAQ:GMAB) announced that it will present pivotal new research from its late-stage oncology portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual...
13 Most Profitable Growth Stocks to Buy Now
The growth factor in investing refers to companies that grow their revenue and earnings at rates significantly above the market.
8 Most Undervalued Healthcare Stocks to Buy According to Analysts
Healthcare prices and expenditures have been rising in the United States.
7 Most Profitable Biotech Stocks To Buy Right Now
With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.
Genmab A/S (GMAB): A Bull Case Theory
We came across a bullish thesis on Genmab A/S (GMAB) on Substack by Oliver | MMMT Wealth. In this article, we will summarize the bulls’ thesis on GMAB.
10 Cash-Rich Undervalued Stocks To Invest In
Currently, big tech and high-growth stocks dominate the stock market, making up a much larger share of the broader market than they have historically.
15 Stocks That Will Go to The Moon According to Analysts
While stocks initially fell based on worries regarding Trump tariffs on America’s major trading partners, major indexes recovered from their initial losses as the President ...
12 Best Growth Stocks to Invest In According to Analysts
Companies experiencing above-average earnings growth, which is often fueled by innovations and market expansions, are known as growth stocks.
Genmab A/S (NASDAQ:GMAB) Q4 2024 Earnings Call Transcript
Operator: Hello, and welcome to the Genmab Full Year 2024 Financial Results Conference Call. As a reminder, this conference call is being recorded.
Why Genmab (GMAB) and Sonic Automotive (SAH) Are Advancing Today
Leerink does not expect Johnson & Johnson (JNJ) to exercise its option to develop GMAB's GEN3014, a treatment candidate for relapsed/refractory multiple myeloma patients.
12 Best Healthcare Stocks to Buy According to Analysts
McKinsey reported that, since 2019, the US healthcare industry witnessed significant financial pressure.
12 High Growth International Stocks to Invest in Now
On January 15, Jurrien Timmer, Director of Global Macro at Fidelity Management & Research Company shared his outlook for 2025.
10 High Growth Healthcare Stocks to Invest in Now
During lean economic times, investing in healthcare stocks is generally regarded as defensive.
10 Worst Performing Healthcare Stocks in 2024
The healthcare industry remains a vital and resilient sector which is driven by advancements in technology, increasing global demand, and an aging population.
10 Worst Performing Biotech Stocks in 2024
Biotechnology stocks are among the most volatile in the market due to their high risk.
12 High Growth Large Cap Stocks to Buy Now
BlackRock highlighted that its portfolio managers are broadly optimistic about US equities.
Genmab A/S (NASDAQ:GMAB) Q3 2024 Earnings Call Transcript
Operator: Hello, and welcome to Genmab's Financial Results Conference Call for the First Nine Months of 2024. As a reminder, this conference call is being recorded.
12 Most Profitable Growth Stocks To Invest In
After the September inflation report, the market did feel a slight bit of panic but it seems to be fading away.
10 Stocks with Biggest Upside Potential According to Hedge Funds
The US equities saw a strong move after the September jobs report exceeded the economists’ estimates.
7 Best Revenue Growth Stocks to Buy According to Analysts
The Fed recently cut the funds rate by 50 basis points which has been considered a bold move by some analysts while others and most of the market have welcomed it with open arms...
10 Best Affordable Stocks Under $40 According to Short Sellers
Several traders tend to profit from stocks through appreciation. However, some do the opposite-- their idea is to profit from stocks when their value declines.
Genmab A/S (NASDAQ:GMAB) Q2 2024 Earnings Call Transcript
Operator: Hello, and welcome to the Genmab First Half 2024 Financial Results Conference Call. As a reminder, this conference call is being recorded.
Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript
Genmab A/S reports earnings inline with expectations. Reported EPS is $0.16 EPS, expectations were $0.16.
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Genmab A/S (NASDAQ:GMAB) Q4 2023 Earnings Call Transcript
Genmab A/S misses on earnings expectations. Reported EPS is $0.14 EPS, expectations were $0.35.
12 High Growth International Stocks to Buy
In this article, we discuss the 12 high growth international stocks to buy.
5 Best High Growth Healthcare Stocks to Buy
In this article, we will take a look at the 5 high growth healthcare stocks to buy.
Genmab A/S (NASDAQ:GMAB) Q3 2023 Earnings Call Transcript
Operator: Hello, and welcome to Genmab's Third Quarter 2023 Financial Results Conference Call. As a reminder, this conference call is being recorded.
Genmab A/S (NASDAQ:GMAB) Q2 2023 Earnings Call Transcript
Operator: Hello, and welcome to Genmab's Second Quarter 2023 Financial Results Conference Call. As a reminder, this conference call is being recorded.
Genmab A/S (NASDAQ:GMAB) Q1 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Genmab's First Quarter 2023 Financial Results Conference Call. As a reminder, this conference call is being recorded.
15 Most Profitable Growth Stocks Now
Growth stocks refer to listed companies that are growing their profits, revenue, or cash flow at a rate that exceeds their competitors and beats the overall market.
5 High Growth International Stocks to Buy
SolarEdge Technologies, Inc. (NASDAQ:SEDG) was incorporated in 2006 and is headquartered in Herzliya, Israel.
Genmab A/S (NASDAQ:GMAB) Q4 2022 Earnings Call Transcript
Operator: Hello, and welcome to the Genmab Full-year 2022 Conference Call. As a reminder, this conference call is being recorded.
13 High Growth Pharma Stocks that are Profitable
One industry that has rapidly evolved with time and impacted millions, if not billions, of lives is the pharmaceutical sector.
Artisan Mid Cap Fund Exited Its Position in Genmab A/S (GMAB) For Better Opportunities
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.
25 Biggest Nordic Companies
The Nordic countries refer to the nation states of Norway, Sweden, Finland, Denmark, and Iceland which are located in Northern Europe.
10 Biotech Stocks With The Biggest Upside
In this article, we discuss the 10 biotech stocks with the biggest upside.
10 Best Immunology Stocks to Invest In
In this article, we discuss the 10 best immunology stocks to invest in.
15 Biggest European Pharmaceutical Companies
Alongside the United States, Europe has some of the most advanced industries and economies in the world.
5 Most Valuable Danish Companies in the World
In this article, we discuss 5 of the most valuable Danish companies in the world.
Analysts Are Downgrading These 10 Stocks
In this article, we discuss the 10 stocks that analysts are downgrading.
Here’s Why Artisan Partners Remains Optimistic in Genmab A/S (GMAB)
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Mid Cap Fund’ second quarter 2021 investor letter – a copy of which can be downloaded...
Here’s Why Artisan Partners Reduced its Genmab A/S (GMAB) Position
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Mid Cap Fund’ first quarter 2021 investor letter – a copy of which can be downloaded...
Is Genmab A/S (GMAB) Stock a Buy For 2021?
Baron Health Care Fund recently published its fourth-quarter commentary – a copy of which can be downloaded here.
